Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 6 studies | 25% ± 10% | |
naive B cell | 6 studies | 17% ± 2% | |
CD4-positive, alpha-beta T cell | 4 studies | 25% ± 8% | |
epithelial cell | 4 studies | 30% ± 5% | |
regulatory T cell | 4 studies | 16% ± 2% | |
CD8-positive, alpha-beta T cell | 3 studies | 23% ± 5% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
endothelial cell | 3 studies | 18% ± 2% | |
myeloid cell | 3 studies | 21% ± 5% | |
lymphocyte | 3 studies | 19% ± 2% | |
memory B cell | 3 studies | 17% ± 1% | |
oligodendrocyte | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 510.87 | 245 / 245 | 99% | 5.53 | 499 / 502 |
brain | 99% | 418.47 | 2626 / 2642 | 100% | 6.81 | 705 / 705 |
breast | 100% | 565.34 | 459 / 459 | 99% | 6.81 | 1109 / 1118 |
thymus | 100% | 644.99 | 653 / 653 | 99% | 13.89 | 600 / 605 |
ovary | 100% | 845.43 | 180 / 180 | 99% | 4.80 | 426 / 430 |
esophagus | 100% | 546.24 | 1444 / 1445 | 99% | 6.29 | 181 / 183 |
lung | 100% | 498.36 | 577 / 578 | 98% | 5.61 | 1136 / 1155 |
bladder | 100% | 515.52 | 21 / 21 | 98% | 5.30 | 493 / 504 |
intestine | 100% | 395.86 | 966 / 966 | 97% | 4.38 | 509 / 527 |
pancreas | 98% | 266.83 | 322 / 328 | 98% | 4.57 | 175 / 178 |
stomach | 99% | 333.23 | 357 / 359 | 97% | 4.76 | 276 / 286 |
adrenal gland | 100% | 501.75 | 258 / 258 | 96% | 3.59 | 220 / 230 |
kidney | 100% | 247.13 | 89 / 89 | 93% | 3.48 | 834 / 901 |
skin | 100% | 782.03 | 1809 / 1809 | 89% | 3.51 | 422 / 472 |
uterus | 100% | 534.38 | 170 / 170 | 89% | 4.57 | 410 / 459 |
adipose | 100% | 516.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.05 | 29 / 29 |
spleen | 100% | 679.90 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.84 | 1 / 1 |
blood vessel | 100% | 321.36 | 1329 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 3.84 | 41 / 45 |
heart | 89% | 160.60 | 762 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 410.85 | 715 / 929 | 0% | 0 | 0 / 0 |
muscle | 72% | 106.33 | 579 / 803 | 0% | 0 | 0 / 0 |
liver | 13% | 15.51 | 29 / 226 | 38% | 0.94 | 154 / 406 |
eye | 0% | 0 | 0 / 0 | 48% | 1.05 | 38 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0021762 | Biological process | substantia nigra development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF430 |
Protein name | Zinc finger protein 430 |
Synonyms | |
Description | FUNCTION: May be involved in transcriptional regulation. |
Accessions | M0QYF1 Q2NKJ9 ENST00000619540.4 ENST00000261560.10 ENST00000623534.3 ENST00000595401.1 Q9H8G1 M0R0L5 ENST00000599548.5 A0A0G2JNR8 A0A0G2JRS6 ENST00000624457.3 M0R392 M0QXG3 ENST00000597922.1 ENST00000594110.5 ENST00000627644.1 ENST00000625163.3 |